TICKERNERD
Menu
VEEVVEEVHealthcare · Health Information Services

VEEV Stock Forecast: Veeva Systems, Inc. Price Predictions for 2026-2027

Last close, 17 Sept 2026
$264
−0.43% on the day

The 28 Wall Street analysts covering Veeva Systems, Inc. hold a median 12-month price target of $300 — +13.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 74 of 100 as at 17 Sept 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$42.9B
Ticker Nerd rank
74 / 100
Median analyst target
$300
Analysts covering
28
Revenue$928.0M+17.6% y/y
Operating income$275.0M
Net income$273.4M
Free cash flow$238.7M
Quarterly, 8 quarters to 31 July 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.1%
1M
+10.7%
YTD
+18.2%
1Y
−3.9%
From 52W high
−13.9%
From 52W low
+74.2%
$151
$306
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

VEEV stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Veeva Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Sept 2026
74 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
95
Quality
90
Volatility
74
Growth
67
Accruals
65
Issuance
61
Value
50
Momentum
34
Size
6

Revisions (95): Analysts have, on balance, been raising their forecasts.

Momentum (34): The shares have been drifting down relative to others.

Size (6): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

VEEV stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on VEEV, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$150$200$250$300$350Oct 25Jan 26Apr 26Jul 26VEEVHigh $350Median $300Low $180

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says28 analysts
19 Buy8 Hold1 Sell
Low $180Median $300High $350

The green dot is the last close — the median target sits +13.7% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 18 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
28 Aug 2026CitigroupMaintainsNeutral$190 → $273
27 Aug 2026BairdMaintainsOutperform$260 → $300
27 Aug 2026BarclaysMaintainsOverweight$275 → $315
27 Aug 2026BMO CapitalMaintainsMarket Perform$175 → $270
27 Aug 2026Canaccord GenuityMaintainsHold$220 → $260
27 Aug 2026Evercore ISI GroupMaintainsIn-Line$185 → $250
27 Aug 2026GuggenheimMaintainsBuy$276 → $310
27 Aug 2026MizuhoMaintainsOutperform$270 → $280
27 Aug 2026Morgan StanleyMaintainsEqual-Weight$215 → $275
27 Aug 2026NeedhamMaintainsBuy$270 → $310
27 Aug 2026Piper SandlerMaintainsOverweight$295 → $320
27 Aug 2026RBC CapitalMaintainsOutperform$275 → $325
27 Aug 2026TD CowenMaintainsBuy$235 → $283
27 Aug 2026Truist SecuritiesMaintainsBuy$262 → $305
27 Aug 2026UBSMaintainsNeutral$190 → $290
24 Aug 2026NeedhamReiteratesBuy$270
24 Aug 2026Piper SandlerAssumesOverweight$235 → $295
20 Aug 2026GuggenheimMaintainsBuy$232 → $276
20 Aug 2026GuggenheimMaintainsBuy—
18 Aug 2026BarclaysMaintainsOverweight$235 → $275

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. VEEV appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

VEEV vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 17 Sept 2026, Veeva Systems, Inc. returned −3.9% against +17.0% for the S&P 500, dividends included.

VEEV vs S&P 500, last 12 monthsTotal return, rebased to 100
6080100120Oct 25Jan 26Apr 26Jul 26VEEVS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

VEEV analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.9%
Analysts raising
24
Analysts cutting
0
Fundamentals

Veeva Systems, Inc. (VEEV) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
43.4×

Cheaper than 17% of US stocks

Price / sales
12.4×

Cheaper than 12% of US stocks

Price / book
5.9×

Cheaper than 17% of US stocks

EV / EBITDA
33.5×

Cheaper than 8% of US stocks

Growth & margins
Revenue growth (YoY)
17.6%

Higher than 66% of US stocks

Earnings growth (YoY)
36.5%

Higher than 69% of US stocks

Gross margin
75.0%

Higher than 87% of US stocks

Operating margin
29.6%

Higher than 87% of US stocks

Net margin
29.3%

Higher than 89% of US stocks

Returns & dividend
Return on equity
14.4%

Higher than 73% of US stocks

Return on assets
7.6%

Higher than 87% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Veeva Systems, Inc. (VEEV) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Veeva Systems, Inc. has a market value of $42.9B and an enterprise value of $36.1B.

  • Revenue in the twelve months to 31 July 2026: $3.5B. The latest quarter grew 17.6% year on year.

  • Net income over the same four quarters: $1.0B, a 29.3% net margin.

  • Diluted earnings per share, trailing twelve months: $6.08.

  • Free cash flow in the twelve months to 31 July 2026: $1.7B.

  • Shares outstanding: 161.8M.

  • Trailing P/E: 43.4×; forward P/E: 25.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Veeva Systems, Inc. employs 7,928 people — $436K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 31 July 2026 · market figures as at 16 Sept 2026

Data provided by Twelve Data

Peers

VEEV vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
VEEVVeeva Systems, Inc.$42.9B
74
TEMTempus AI, Inc.$14.4B
24
BTSGBrightSpring Health Services, Inc.$11.0B
91
HQYHealthEquity, Inc.$8.1B
94
HNGEHinge Health, Inc.$7.3B
79
WAYWaystar Holding Corp.$5.1B
34
DOCSDoximity, Inc.$4.9B
61

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Veeva Systems, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest VEEV news & analysis

Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know

Zacks Investment Research · 17 Sept 2026neutral

Veeva Systems (VEEV) has been drawing significant attention from Zacks.com users recently, prompting Zacks to highlight facts that could impact the company's prospects. The piece aims to inform investors about developments affecting the stock.

Why it matters — The elevated investor interest signals that VEEV watchers may want to stay informed on factors that could influence the company's prospects.

Veeva Systems (VEEV) Just Flashed Golden Cross Signal: Do You Buy?

Zacks Investment Research · 15 Sept 2026positive

Zacks Investment Research reported that Veeva Systems (VEEV) flashed a golden cross signal after the stock reached a significant support level and broke through its 20-day moving average, which the source describes as suggesting a short-term bullish trend.

Why it matters — This technical signal is relevant to VEEV watchers because it points to a possible short-term bullish shift in the stock's momentum.

Leading Biotech Selects Veeva Vault CRM Globally

PRNewsWire · 15 Sept 2026positive

Veeva Systems announced that Amgen plans to deploy Veeva Vault CRM globally, extending a collaboration that has spanned more than a decade. The deployment is described as an agentic CRM foundation aimed at helping accelerate the delivery of innovative medicines to patients worldwide.

Why it matters — A major biotech expanding its global use of Veeva Vault CRM signals continued adoption and deepening of a long-standing commercial relationship for Veeva.

Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target

MarketBeat · 14 Sept 2026positive

At a Wells Fargo healthcare technology event, Veeva Systems executives described artificial intelligence as an incremental growth opportunity that could extend beyond its previously stated target of $6 billion in revenue by 2030.

Why it matters — The positioning of AI as an additional growth driver suggests Veeva sees a path to outpace its existing long-term revenue goals, which is relevant to investors tracking the company's growth narrative.

Veeva Systems Unveils Falcon AI as Commercial Growth Gains Momentum

MarketBeat · 14 Sept 2026positive

Veeva Systems CFO Brian Van Wagener stated the company is expanding its artificial intelligence roadmap, announcing Falcon AI while continuing to see broad-based growth across its life sciences software portfolio.

Why it matters — A VEEV watcher would care because it signals the company is advancing its AI strategy alongside sustained growth in its core life sciences software business.

FAQ

Frequently asked questions about VEEV stock

What is the VEEV stock price forecast for 2026-2027?

The 28 Wall Street analysts covering Veeva Systems, Inc. have a median 12-month price target of $300, with estimates ranging from $180 to $350. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is VEEV stock a buy right now?

Of the 28 analysts covering Veeva Systems, Inc., 19 rate it a Buy, 8 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Veeva Systems, Inc. 74 out of 100 across roughly 4,600 US stocks as at 17 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank VEEV?

As at 17 Sept 2026, Veeva Systems, Inc. ranks 74 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Revisions (95 of 100).

Will VEEV stock go up?

No one can know that. What the data says: the median 12-month target from 28 analysts implies +13.7% from the last close, and Ticker Nerd's factor model ranks Veeva Systems, Inc. 74 out of 100 as at 17 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the VEEV stock forecast for 2030?

No analyst covering Veeva Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for VEEV are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $180 to $350 over the next 12 months.

How has VEEV stock performed over the past year?

Veeva Systems, Inc. returned -3.9% over the 12 months to 17 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Veeva Systems, Inc. do?

Veeva Systems Inc. is a cloud software company that provides industry-specific solutions for the global life sciences sector.

What is the latest news on VEEV?

The most recent item we track (Zacks Investment Research, 17 Sept 2026): "Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know". Veeva Systems (VEEV) has been drawing significant attention from Zacks.com users recently, prompting Zacks to highlight facts that could impact the company's prospects. The piece aims to inform investors about developments affecting the stock.

Company

About Veeva Systems, Inc.

Veeva Systems Inc. is a cloud software company that provides industry-specific solutions for the global life sciences sector. Veeva Systems Inc. offers applications, data, and consulting services designed to support pharmaceutical, biotechnology, and medical device companies across research and development, quality, and commercial operations. Its product portfolio includes platforms for clinical, regulatory, quality, and field activities, along with customer relationship management, content management, analytics, and data services tailored to life sciences workflows. The company also delivers cloud-based tools that help organizations manage complex processes from drug development through commercialization. Veeva Systems Inc. plays a central role in the life sciences technology market by combining software and data in a specialized industry cloud built for highly regulated environments. Founded in 2007 and headquartered in Pleasanton, California, the company focuses on serving customers that need compliant, scalable digital systems for critical business functions.

CEO Mr. Peter P. Gassner · 7,928 employees · United States · https://www.veeva.com